A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC

NCT03134872 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

419

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Neoplasms
Carcinoma, Non-Small-Cell Lung
Respiratory Tract Neoplasms
Thoracic Neoplasms
Lung Diseases
Respiratory Tract Disease
Neoplasms by Site
Neoplasm, Bronchial
Carcinoma, Bronchogenic

Interventions

BIOLOGICAL: SHR-1210
DRUG: Carboplatin
DRUG: Pemetrexed

Sponsor

Jiangsu HengRui Medicine Co., Ltd.